Globe Life (NYSE:GL) Issues FY 2025 Earnings Guidance

Globe Life (NYSE:GL) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided EPS guidance of 13.200-13.900 for the period, compared to the consensus EPS estimate of 13.250. The company issued revenue guidance of -. Globe Life also updated its FY 2024 guidance to 12.200-12.400 EPS.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on GL shares. TD Cowen began coverage on shares of Globe Life in a research note on Wednesday, October 9th. They set a “buy” rating and a $150.00 target price for the company. Wells Fargo & Company boosted their price objective on shares of Globe Life from $108.00 to $117.00 and gave the company an “overweight” rating in a research report on Thursday, October 10th. Keefe, Bruyette & Woods reaffirmed an “outperform” rating and set a $118.00 target price (up from $110.00) on shares of Globe Life in a research report on Wednesday, July 31st. Truist Financial boosted their price target on Globe Life from $80.00 to $90.00 and gave the company a “hold” rating in a report on Friday, July 26th. Finally, Morgan Stanley raised their price objective on Globe Life from $66.00 to $83.00 and gave the stock an “equal weight” rating in a report on Monday, August 19th. Five research analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $117.40.

Globe Life Stock Down 0.2 %

Globe Life stock traded down $0.21 during mid-day trading on Wednesday, reaching $110.86. 640,291 shares of the company were exchanged, compared to its average volume of 1,601,265. Globe Life has a 12-month low of $38.95 and a 12-month high of $132.00. The business has a fifty day moving average of $104.60 and a 200 day moving average of $90.63. The firm has a market cap of $9.98 billion, a P/E ratio of 10.60 and a beta of 0.81. The company has a debt-to-equity ratio of 0.31, a quick ratio of 0.05 and a current ratio of 0.05.

Globe Life (NYSE:GL) last issued its quarterly earnings data on Wednesday, July 24th. The company reported $2.97 earnings per share for the quarter, topping analysts’ consensus estimates of $2.90 by $0.07. Globe Life had a return on equity of 21.93% and a net margin of 18.47%. The firm had revenue of $1.44 billion during the quarter, compared to analysts’ expectations of $1.45 billion. During the same period in the prior year, the business posted $2.61 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. Research analysts anticipate that Globe Life will post 11.93 earnings per share for the current fiscal year.

Globe Life Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 1st. Shareholders of record on Friday, October 4th will be given a dividend of $0.24 per share. This represents a $0.96 annualized dividend and a dividend yield of 0.87%. The ex-dividend date of this dividend is Friday, October 4th. Globe Life’s payout ratio is 9.17%.

Insider Transactions at Globe Life

In other Globe Life news, Director Mary E. Thigpen acquired 3,000 shares of the firm’s stock in a transaction dated Friday, July 26th. The stock was purchased at an average price of $90.20 per share, for a total transaction of $270,600.00. Following the acquisition, the director now owns 15,605 shares in the company, valued at approximately $1,407,571. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 1.51% of the company’s stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.